2019
DOI: 10.3390/cells8121644
|View full text |Cite
|
Sign up to set email alerts
|

Genetically Engineered Lung Cancer Cells for Analyzing Epithelial–Mesenchymal Transition

Abstract: Cell plasticity, defined as the ability to undergo phenotypical transformation in a reversible manner, is a physiological process that also exerts important roles in disease progression. Two forms of cellular plasticity are epithelial–mesenchymal transition (EMT) and its inverse process, mesenchymal–epithelial transition (MET). These processes have been correlated to the poor outcome of different types of neoplasias as well as drug resistance development. Since EMT/MET are transitional processes, we generated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 57 publications
0
6
0
Order By: Relevance
“…The expression of vimentin may play a key role in cell migratory ability, since migratory ability can be inhibited when vimentin expression is suppressed (Wawruszak et al 2019). The expression level of vimentin is positively associated with the invasive and migratory ability of tumor cells, such as ovarian cancer, cervical cancer, endometrial cancer (Zhou et al 2014), breast cancer (Xu et al 2020), tongue squamous cell carcinoma (Hussein et al 2018), lung cancer (Kielbus et al 2019), and prostate cancer (Kaufhold and Bonavida 2014). In the present study, overexpression of HSP70 can downregulate the expression of vimentin and abate the process of EMT; however, the specific molecular mechanism and signaling pathways involved remain unclear; thus, further studies are required.…”
Section: Discussionmentioning
confidence: 99%
“…The expression of vimentin may play a key role in cell migratory ability, since migratory ability can be inhibited when vimentin expression is suppressed (Wawruszak et al 2019). The expression level of vimentin is positively associated with the invasive and migratory ability of tumor cells, such as ovarian cancer, cervical cancer, endometrial cancer (Zhou et al 2014), breast cancer (Xu et al 2020), tongue squamous cell carcinoma (Hussein et al 2018), lung cancer (Kielbus et al 2019), and prostate cancer (Kaufhold and Bonavida 2014). In the present study, overexpression of HSP70 can downregulate the expression of vimentin and abate the process of EMT; however, the specific molecular mechanism and signaling pathways involved remain unclear; thus, further studies are required.…”
Section: Discussionmentioning
confidence: 99%
“…TGFβ was produced in HEK293 cells, as previously reported [44], where the medium of cells transfected with a plasmid coding TGFβ was collected and transferred to 96 well plate containing cells expressing the TWIST1-GLuc reporter construct. As a control, we used media from mock-transfected HEK-293T cells.…”
Section: Methodsmentioning
confidence: 99%
“…Wound-healing assay. For the Wound-healing assay cell lines of H1299 and H2170 VRCs (vimentin reporter cells) 38 were seeded into 12-well plates at a density 5 × 10 4 cells/mL. One day later were co-transfected with one half of Cas9 protein (pCMV-Cas4.5C) driven by general promoter, construct with EGxxFP reporter plasmid, Cetn1 gRNA and second half of Cas9 TBD-Cas4.5N under the specific promoter activated during EMT -under the control of TWIST1, resulted in EGFP expression.…”
Section: Molecular Cloningmentioning
confidence: 99%